PRTN3 and rheumatoid arthritis: B cells have an apparent role in the production of RA associated autoantibodies, such as rheumatoid factor (RF) and anti citrullinated peptide antibodies (ACPA), and B cell depletion therapy using anti-CD20 is efficacious for RA patients including those refractory to TNF-blockade10.